Venus Remedies says it has secured Argentina marketing approval for Ceftriaxone, a key antibiotic used to treat serious bacterial infections. The authorization is a major milestone in the company’s Latin America expansion, with Argentina highlighted as an important market for critical care therapies. The move strengthens Venus Remedies’ international presence and its focus on more accessible anti-infective treatments.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
